As expected, tumor growth in KPOVA-Cxcl9-inoculated mice was significantly suppressed relative to that in KPOVA-mock-inoculated mice after treatment with either anti–PD-1 antibody or isotype control (Figure 4B). The gene discussed is CXCL9; the disease is neoplasm.